SG11201810847RA - Non-invasive diagnostic imaging agent for heart disease - Google Patents

Non-invasive diagnostic imaging agent for heart disease

Info

Publication number
SG11201810847RA
SG11201810847RA SG11201810847RA SG11201810847RA SG11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA SG 11201810847R A SG11201810847R A SG 11201810847RA
Authority
SG
Singapore
Prior art keywords
heart disease
imaging agent
diagnostic imaging
invasive diagnostic
invasive
Prior art date
Application number
SG11201810847RA
Inventor
Yoshifumi MAYA
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of SG11201810847RA publication Critical patent/SG11201810847RA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0453—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention addresses the problem of providing a technique for detecting a lesion of a heart disease in a non-invasive manner. The present invention 5 provides a non-invasive diagnostic imaging agent for a heart disease, which contains a radioactively labeled compound capable of binding to an aldosterone synthase or a salt thereof as an active ingredient. - 1 - Figure 1 Figure 2 - 2 - Figure 3 Figure 4 - 3 - Figure 5 Figure 6 - 4 - Figure 7 - 5 - Figure 8 Figure 9 - 6 - Figure 10 Figure 11 - 7 - Figure 12 Figure 13 - 8 - Figure 14
SG11201810847RA 2016-06-10 2017-06-09 Non-invasive diagnostic imaging agent for heart disease SG11201810847RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016115806 2016-06-10
PCT/JP2017/021442 WO2017213247A1 (en) 2016-06-10 2017-06-09 Non-invasive diagnostic imaging agent for heart disease

Publications (1)

Publication Number Publication Date
SG11201810847RA true SG11201810847RA (en) 2019-01-30

Family

ID=60577959

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810847RA SG11201810847RA (en) 2016-06-10 2017-06-09 Non-invasive diagnostic imaging agent for heart disease

Country Status (9)

Country Link
US (1) US20190255199A1 (en)
EP (1) EP3470091A4 (en)
JP (1) JPWO2017213247A1 (en)
KR (1) KR20190016971A (en)
CN (1) CN109310787A (en)
AU (1) AU2017278446A1 (en)
CA (1) CA3026617A1 (en)
SG (1) SG11201810847RA (en)
WO (1) WO2017213247A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11266753B2 (en) 2017-12-28 2022-03-08 Nihon Medi-Physics Co., Ltd. 2-[5-(imidazol-1-ylmethyl)pyridin-3-yl]benzimtdazole derivative compound, and medicament including same
JP2021130610A (en) * 2018-05-08 2021-09-09 日本メジフィジックス株式会社 Non-invasive diagnostic imaging agent for heart disease

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE484507T1 (en) * 2007-03-29 2010-10-15 Novartis Ag HETEROCYCLIC SPIR COMPOUNDS
JP5196561B2 (en) * 2007-11-07 2013-05-15 独立行政法人放射線医学総合研究所 Nuclear medicine diagnostic medicine
DE102008022221A1 (en) 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitors of human aldosterone synthase CYP11B2
WO2011064376A1 (en) * 2009-11-30 2011-06-03 Novartis Ag Imidazole derivatives as aldosterone synthase inhibitors
EP2394668A1 (en) 2010-06-01 2011-12-14 Julius-Maximilians-Universität Würzburg PET radiopharmaceuticals for differential diagnosis between bilateral and unilateral conditions of primary hyperaldosteronism
US9353081B2 (en) * 2011-09-23 2016-05-31 Hoffmann-La Roche Inc. Bicyclic dihydroquinoline-2-one derivatives
JP6048958B2 (en) 2012-12-27 2016-12-21 日本メジフィジックス株式会社 Diagnostic agents for adrenal diseases
JP2015093833A (en) 2013-11-08 2015-05-18 日本メジフィジックス株式会社 Radioactive halogen labeled compounds or salts thereof, and pharmaceuticals containing the same
JP2015093832A (en) 2013-11-08 2015-05-18 日本メジフィジックス株式会社 Radioactive halogen labeled compounds or salts thereof, and pharmaceuticals containing the same
JP2015093831A (en) 2013-11-08 2015-05-18 日本メジフィジックス株式会社 Aldosterone synthase inhibitor
JP2015110563A (en) 2013-11-08 2015-06-18 日本メジフィジックス株式会社 Aldosterone synthase inhibitor
JP2015193545A (en) 2014-03-31 2015-11-05 国立大学法人京都大学 2-(3-pyridinyl)-1h-benzimidazole derivative compound, and radioactive pharmaceuticals containing the same
JP6313098B2 (en) 2014-04-04 2018-04-18 イーデーエム株式会社 Thermal printer
US10189815B2 (en) * 2014-06-26 2019-01-29 Nihon Medi-Physics Co., Ltd. 2-(3-pyridinyl)-1H-benzimidazole derivative compound and medicine containing same

Also Published As

Publication number Publication date
AU2017278446A1 (en) 2018-12-20
JPWO2017213247A1 (en) 2019-04-04
EP3470091A1 (en) 2019-04-17
CN109310787A (en) 2019-02-05
WO2017213247A1 (en) 2017-12-14
EP3470091A4 (en) 2019-06-19
US20190255199A1 (en) 2019-08-22
KR20190016971A (en) 2019-02-19
CA3026617A1 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
EP3370617A4 (en) Noninvasive imaging and treatment system for cardiac arrhythmias
WO2015134464A3 (en) Targeted therapeutics
MX2022002401A (en) Radiopharmaceuticals, radioimaging agents, and uses thereof.
GEP20237479B (en) Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer
JP2014221779A5 (en)
EP3466416A3 (en) A binding moiety-drug conjugate comprising a hsp90 binding moiety and a cytotoxic effector moiety
MX2015005948A (en) Polypeptides for blood brain barrier transport.
WO2015066053A8 (en) Targeted therapeutics
WO2015171558A3 (en) BENZENESULFONAMIDO AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORγ AND THE TREATEMENT OF DISEASE
ZA202001528B (en) Non-invasive diagnostic of non-alcoholic fatty liver diseases, non-alcoholic steatohepatitis and/or liver fibrosis
MX2020011100A (en) Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof.
MX2015012528A (en) Macrocyclic salt-inducible kinase inhibitors.
EP4397656A3 (en) Hdac6 inhibitors and imaging agents
EA201890221A1 (en) HBED BISPHOSPHONATE, THEIR CONJUGATES WITH RADIOMETAL AND THEIR USE AS MEDICAL TREATMENT DIAGNOSTIC AGENTS
MX2018002338A (en) Probes for imaging huntingtin protein.
EP3375787A4 (en) Peptide thiourea derivative, radioisotope labeled compound containing same, and pharmaceutical composition containing same as active ingredient for treating or diagnosing prostate cancer
WO2017105565A3 (en) Compositions for therapeutics, targeted pet imaging and methods of their use
MX2015012526A (en) Macrocyclic rip2 kinase inhibitors.
SG11201810847RA (en) Non-invasive diagnostic imaging agent for heart disease
WO2015062726A3 (en) Hcbi sequences as an early marker for the future development of cancer and diseases of the cns and as a target for cancer treatment and prevention
WO2015163961A3 (en) Beta and alpha emission tomography for three-dimensional autoradiography
EP3741105A4 (en) Ionizing radiation-free dental imaging by near-infrared fluorescence, and related systems
IL263047B (en) Cardiac surgery cryoprobe
WO2015145447A3 (en) Glucose analogs for diagnosis of disease states
EP4356967A3 (en) Compounds for use as imaging agents